Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1

Status

Recruiting 21Not yet recruiting 5Completed 5Active not recruiting 4Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 2Rectal Neoplasms 1Pathologic Complete Response 1Esophageal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 60Magnetic Resonance Spectroscopy 41Carboplatin 32Gemcitabine 29Cyclophosphamide 29Cisplatin 25Biopsy 25Bevacizumab 24pembrolizumab 23Radiotherapy 22Paclitaxel 22Standard of Care 21Injections 21Drug Therapy 21Capecitabine 21fludarabine 20Oxaliplatin 20venetoclax 19Nivolumab 18toripalimab 17Interviews as Topic 17Dexamethasone 16Blood Specimen Collection 16tislelizumab 14Radiosurgery 14cemiplimab 13anlotinib 13Azacitidine 13Pemetrexed 12Irinotecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Folfox protocol × 90 days × Clear all
NCT07622017 2026-06-02

K-BOOST

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Not yet recruiting
24 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07603375 2026-05-29

TNT Esophagus

Duke University

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT07543783 2026-04-28

Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial

Third Affiliated Hospital, Sun Yat-Sen University

Phase 2 Not yet recruiting
38 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07522411 2026-04-13

Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma

Tongji Hospital

Phase 1/2 Not yet recruiting
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting
394 enrolled

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡